Citation: Ding Y (2022) Adalimumab Biosimilar Adalimumab-adbm and Reference Product Population Pharmacokinetics in Healthy Persons and Patients with Rheumatoid Arthritis to Determine Pharmacokinetic Similarities. J Pharmacokinet Exp Ther 6: 151.

Copyright: © 2022 Ding Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.